Invention Grant
- Patent Title: Quinazolines as potassium ion channel inhibitors
- Patent Title (中): 喹唑啉作为钾离子通道抑制剂
-
Application No.: US13393328Application Date: 2010-09-01
-
Publication No.: US08575184B2Publication Date: 2013-11-05
- Inventor: James A. Johnson , John Lloyd , Heather Finlay , Ji Jiang , James Neels , Naveen Kumar Dhondi , Prashantha Gunaga , Abhisek Banerjee
- Applicant: James A. Johnson , John Lloyd , Heather Finlay , Ji Jiang , James Neels , Naveen Kumar Dhondi , Prashantha Gunaga , Abhisek Banerjee
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten; Terence J. Bogie
- International Application: PCT/US2010/047430 WO 20100901
- International Announcement: WO2011/028741 WO 20110310
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/517 ; C07D239/72 ; C07D401/00
Abstract:
A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
Public/Granted literature
- US20120232068A1 QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS Public/Granted day:2012-09-13
Information query
IPC分类:
